These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 6990171)

  • 1. Dopaminergic control of serum potassium.
    Bevilacqua M; Norbiato G; Raggi U; Micossi P; Baggio E; Prandelli M
    Metabolism; 1980 Apr; 29(4):306-10. PubMed ID: 6990171
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of metoclopramide, a dopamine antagonist, on secretion of aldosterone and renin release in patients with primary aldosteronism.
    Mizuno K; Yamazaki M; Ikeda K; Yaginuma K; Hashimoto S; Fukuchi S
    Jpn Heart J; 1983 Nov; 24(6):917-24. PubMed ID: 6323781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The effect of dopaminergic antagonists on plasma aldosterone in normal subjects and patients with hypopituitarism].
    Shikuma R; Yoshimura M; Takashina R; Yamazaki H; Kambara S; Ijichi H
    Nihon Naibunpi Gakkai Zasshi; 1984 Sep; 60(9):1041-5. PubMed ID: 6394371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopaminergic regulation of aldosterone secretion: its pathophysiologic significance in subsets of primary aldosteronism.
    Naruse M; Naruse K; Yoshimoto T; Tanaka M; Tanabe A; Imaki T; Shibasaki T; Demura R; Demura H
    Hypertens Res; 1995 Jun; 18 Suppl 1():S59-64. PubMed ID: 8529076
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopaminergic modulation of aldosterone secretion: effect of sodium balance and postural changes.
    García-Robles R; Ruilope L; Mancheño E; Hurtado A; Alcázar JM; Varela C; de la Calle H; Rodicio JL; Sancho J
    Rev Esp Fisiol; 1984 Mar; 40(1):63-8. PubMed ID: 6087430
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of metergoline on the aldosterone-stimulating properties of metoclopramide.
    Opocher G; Murgia A; Boscaro M; D'Agostino D; Fallo F; Mantero F
    J Steroid Biochem; 1983 Jul; 19(1B):531-6. PubMed ID: 6350721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of metoclopramide and bromocriptine on the renin-angiotensin-aldosterone system in man. Dopaminergic control of aldosterone.
    Carey RM; Thorner MO; Ortt EM
    J Clin Invest; 1979 Apr; 63(4):727-35. PubMed ID: 438333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Enhanced response of plasma aldosterone to metoclopramide in essential hypertension.
    Stern N; Sowers JR; Tuck M; Eshkol A; Lunenfeld B; Rosenthal T
    J Hypertens; 1984 Apr; 2(2):209-14. PubMed ID: 6398336
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Central and peripheral effects of dopamine on the renin-angiotensin-aldosterone system in conscious rats.
    Kondo K; Suzuki H; Handa M; Nagahama S; Yasui T; Fujimaki M; Ogihara T; Saruta T
    Jpn Circ J; 1981 Sep; 45(9):1121-5. PubMed ID: 7029031
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of dopaminergic blockade on plasma aldosterone in acquired hypoaldosteronism.
    Krishna GG; Chusid P; Hoeldtke RD
    Nephron; 1987; 47(3):184-9. PubMed ID: 3683686
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tonic dopaminergic suppression of plasma aldosterone.
    Noth RH; McCallum RW; Contino C; Havelick J
    J Clin Endocrinol Metab; 1980 Jul; 51(1):64-9. PubMed ID: 7380993
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic control of aldosterone secretion in hypertensive patients chronically treated with an angiotensin converting enzyme inhibitor.
    Waeber B; Nussberger J; Schaller MD; Gomez HJ; Brunner HR
    Horm Metab Res; 1986 Jan; 18(1):60-3. PubMed ID: 3005150
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduced response to metoclopramide and anomalous rising response to upright posture of plasma aldosterone concentration in Japanese patients with aldosterone-producing adenoma.
    Mune T; Morita H; Yasuda K; Yamakita N; Miura K
    J Clin Endocrinol Metab; 1993 Oct; 77(4):1020-7. PubMed ID: 8408449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dopaminergic regulation of extrarenal potassium metabolism.
    Sager PT; DeFronzo RA
    Miner Electrolyte Metab; 1987; 13(6):385-92. PubMed ID: 3320723
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of sodium homeostasis on dopaminergic modulation of aldosterone, renin, and prolactin secretion in man.
    Sowers JR; Glub MS; Eggena PH; Catania RA
    J Clin Endocrinol Metab; 1982 Jan; 54(1):121-6. PubMed ID: 7033264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aldosterone suppression with dopamine infusion in low-renin hypertension.
    Holland OB; Thomas C; Brown H; Schindewolf D; Hillier Y; Gomez-Sanchez C
    J Clin Invest; 1983 Sep; 72(3):754-66. PubMed ID: 6309909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of metoclopramide on aldosterone and regulatory factors in man.
    Gilchrist NL; Espiner EA; Nicholls MG; Donald RA
    Clin Endocrinol (Oxf); 1984 Jul; 21(1):1-7. PubMed ID: 6086181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for a role of a serum factor stimulated by metoclopramide in regulating aldosterone secretion.
    Bevilacqua M; Scorza D; Meroni R; Vago T; Dagani R; Malacco E; Norbiato G
    Biochem Biophys Res Commun; 1984 Feb; 119(1):95-100. PubMed ID: 6704135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of atrial natriuretic hormone on metoclopramide-induced stimulation of aldosterone.
    Shenker Y; Meranda D; Clinkingbeard C; Lawrence D; Koch D
    J Lab Clin Med; 1992 Aug; 120(2):297-304. PubMed ID: 1323636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dopaminergic regulation of 18-hydroxycorticosterone and aldosterone secretion in man.
    Sowers JR; Beck FW
    Acta Endocrinol (Copenh); 1983 Feb; 102(2):258-64. PubMed ID: 6338674
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.